What is TARS's dilution risk score?

TARS currently has a DilutionScore of 14/100, indicating low dilution risk. DilutionWatch monitors TARS SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for TARS?

DilutionWatch tracks 25 SEC filing types for TARS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect TARS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For TARS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for TARS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for TARS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

TARS Dilution Risk Score: 14/100 (LOW)

📊 Score Breakdown

📋 Offering Ability

22

💰 Cash Runway

0

📊 Float Risk

30

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

0%

No significant dilution signals detected for TARS.

🔔 Track TARS — Get forecast alerts →

💹 Market Data

Market Cap$2.56B

Shares Outstanding43.02M

Float32.12M

Cash$388.73M

Debt$72.60M

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 21.0% shares (2026Q1 vs prior)

256 institutional holders · 55.06M shares

#1 MORGAN STANLEY 5.90M shares

#2 JANUS HENDERSON GROUP PLC 4.48M shares

#3 Deep Track Capital, LP 3.60M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.89M

Days to Cover6.2

% of Float18.3%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026

xbrl XBRL CONVERTIBLE Dec 31, 2020

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for TARS Shareholders

Tarsus Pharmaceuticals, Inc. (TARS) has a DilutionScore of 14/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 312,500 outstanding warrants for TARS. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for TARS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for TARS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →